Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,358
Total Claims
$884K
Drug Cost
1,093
Beneficiaries
$809
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+58%
Opioid rate vs peers
72.4% vs 45.9% avg
+68%
Cost per patient vs peers
$809 vs $483 avg
+126%
Brand preference vs peers
9.3% vs 4.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
72.4%
Opioid Rate
7,499
Opioid Claims
$729K
Opioid Cost
26.1%
Long-Acting Rate
This provider's opioid prescribing rate of 72.4% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 966 claims · $536K
Generic: 9,392 claims · $348K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 225 | $193K |
| Oxycodone Hcl | 120 | $87K |
| Tapentadol Hcl | 52 | $70K |
| Buprenorphine Hcl | 104 | $64K |
| Hydrocodone/Acetaminophen | 1,711 | $49K |
| Oxycodone Hcl/Acetaminophen | 978 | $38K |
| Morphine Sulfate | 890 | $33K |
| Buprenorphine | 147 | $33K |
| Oxycodone Hcl | 1,155 | $27K |
| Pregabalin | 511 | $23K |
| Tapentadol Hcl | 15 | $21K |
| Buprenorphine | 24 | $18K |
| Gabapentin | 576 | $15K |
| Erenumab-Aooe | 19 | $15K |
| Hydromorphone Hcl | 35 | $14K |
Prescribing Profile
43
Unique Drugs
26.0
Anomaly Score
Patient Profile
73
Avg Age
61%
Female
1.55
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About